Pharma’s contractors might finally be on the rebound
IQVIA — a multibillion-dollar firm that sells services to the drug industry — saw its share price rise 5% yesterday after reporting financial results that beat Wall Street’s estimates, bucking months…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hello, everyone. Damian here with a look at a complicatedly important ALS study, biotech’s latest volatility, and some green shoots for a downtrodden part of the industry.
What's Your Reaction?
